Money Concepts Capital’s iShares Biotechnology ETF IBB Stock Holding History

Money Concepts Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$261K	Buy	1,545 +11	+0.7%	+$1.88K	0.01%	488
2025 Q4	$259K	Buy	1,534 +21	+1%	+$3.41K	0.01%	461
2025 Q3	$218K	Buy	+1,513	New	+$207K	0.01%	439
2025 Q1	–	Sell	-1,566	Closed	-$207K	–	424
2024 Q4	$207K	Sell	1,566 -7	-0.4%	-$984	0.02%	391
2024 Q3	$229K	Buy	1,573 +6	+0.4%	+$868	0.02%	380
2024 Q2	$215K	Hold	1,567	–	–	0.02%	368
2024 Q1	$215K	Buy	1,567 +1	+0.1%	+$137	0.02%	368
2023 Q4	$213K	Buy	+1,566	New	+$191K	0.02%	365
2023 Q1	–	Sell	-2,833	Closed	-$372K	–	1617
2022 Q4	$372K	Buy	2,833 +2,375	+519%	+$307K	0.02%	504
2022 Q3	$54K	Sell	458 -333	-42%	-$41.4K	﹤0.01%	699
2022 Q2	$95K	Sell	791 -2,596	-77%	-$308K	0.01%	573
2022 Q1	$441K	Buy	3,387 +2,740	+423%	+$357K	0.02%	479
2021 Q4	$99K	Buy	+647	New	+$100K	0.01%	553
2021 Q1	$69K	Buy	457 +1	+0.2%	+$159	0.01%	545
2020 Q4	$69K	Buy	+456	New	+$65.2K	0.01%	494

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Money Concepts Capital's IBB Position: Q1 2026 in Review

Money Concepts Capital increased its iShares Biotechnology ETF (IBB) stake by 0.72% in Q1 2026, buying an estimated $1.88K and bringing the position to 1,545 shares worth $261K. The position accounts for 0.01% of the portfolio, ranked #488.

Money Concepts Capital first reported a position in IBB in Q4 2020 and has held it in 15 quarters since. The position peaked at $441K in Q1 2022. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Money Concepts Capital held 1,545 shares of iShares Biotechnology ETF worth $261K as of Q1 2026.
Money Concepts Capital bought 11 iShares Biotechnology ETF shares in Q1 2026, an estimated $1.88K.
iShares Biotechnology ETF made up 0.01% of Money Concepts Capital's portfolio in Q1 2026, its #488 holding.
Money Concepts Capital first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 15 quarters since.
Money Concepts Capital's iShares Biotechnology ETF position peaked at $441K in Q1 2022.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Money Concepts Capital's 13F filing for Q1 2026, filed 30 Apr 2026.